Last reviewed · How we verify
AMMONIUM CHLORIDE
At a glance
| Generic name | AMMONIUM CHLORIDE |
|---|---|
| Sponsor | B Braun |
| Drug class | ammonium chloride |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
| First approval | 1978 |
Approved indications
- Common cold
- Cough
- Nasal congestion
- Nasal discharge
Common side effects
Key clinical trials
- Antiplaque Efficacy and Patient Reported Outcome of Chlorohexidine, Cetylpyridinium Chloride, and Essential Oil Mouthwashes in Orthodontic Patients (NA)
- Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support (PHASE2,PHASE3)
- Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection (PHASE4)
- Effectiveness of Ammonium Chloride in Reducing Viral Load
- A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa (PHASE2)
- Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma (PHASE2)
- Bethanechol Prior to Pancreatic Surgery (EARLY_PHASE1)
- Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AMMONIUM CHLORIDE CI brief — competitive landscape report
- AMMONIUM CHLORIDE updates RSS · CI watch RSS
- B Braun portfolio CI